Search Results - "Blonde, L"

Experimental observation of asymmetrical microwave jets and far-field distribution generated by a dual-material system by Varghese, B., Shramkova, O., Minard, P., Blondé, L., Drazic, V., Allié, V.

“…In this paper, we report the experimental and numerical investigation of plane wave diffraction by an all-dielectric dual-material cuboid. Edge diffraction by…”
Get full text

The safety and efficacy of liraglutide with or without oral antidiabetic drug therapy in type 2 diabetes: an overview of the LEAD 1-5 studies by Blonde, L., Russell-Jones, D.

“…Liraglutide is a new glucagon‐like peptide‐1 (GLP‐1) receptor agonist and a true GLP‐1 analogue. After successful phase 2 studies, liraglutide was assessed in…”
Get full text

Patient-directed titration for achieving glycaemic goals using a once-daily basal insulin analogue: an assessment of two different fasting plasma glucose targets - the TITRATE study by Blonde, L, Merilainen, M, Karwe, V, Raskin, P

“…To compare efficacy and safety of two fasting plasma glucose (FPG) titration targets [4.4-6.1 mmol/l (80-110 mg/dl) and 3.9-5.0 mmol/l (70-90 mg/dl)] using a…”
Get full text

Hypoglycaemia is reduced with use of inhaled Technosphere® Insulin relative to insulin aspart in type 1 diabetes mellitus by Seaquist, E. R., Blonde, L., McGill, J. B., Heller, S. R., Kendall, D. M., Bumpass, J. B., Pompilio, F. M., Grant, M. L.

“…Aim To evaluate the effect of final HbA1c levels on the incidences of hypoglycaemia in participants with type 1 diabetes treated with inhaled Technosphere®…”
Get full text

Interim analysis of the effects of exenatide treatment on A1C, weight and cardiovascular risk factors over 82 weeks in 314 overweight patients with type 2 diabetes by Blonde, L., Klein, E. J., Han, J., Zhang, B., Mac, S. M., Poon, T. H., Taylor, K. L., Trautmann, M. E., Kim, D. D., Kendall, D. M.

“…Aim:  Exenatide, an incretin mimetic for the adjunct treatment of type 2 diabetes (DM2), reduced A1C and weight in 30‐week placebo‐controlled trials. This…”
Get full text

Comparison of liraglutide versus other incretin-related anti-hyperglycaemic agents by Blonde, L., Montanya, E.

“…The two classes of incretin‐related therapies, dipeptidyl peptidase‐4 (DPP‐4) inhibitors and glucagon‐like peptide‐1 receptor agonists (GLP‐1 RAs), have become…”
Get full text

Improvement in glycated haemoglobin evaluated by baseline body mass index: a meta-analysis of the liraglutide phase III clinical trial programme by Montanya, E., Fonseca, V., Colagiuri, S., Blonde, L., Donsmark, M., Nauck, M. A.

“…In the liraglutide clinical trial programme, liraglutide 1.2 and 1.8 mg were found to effectively lower glycated haemoglobin (HbA1c) in patients with type 2…”
Get full text

Progression to insulin therapy among patients with type 2 diabetes treated with sitagliptin or sulphonylurea plus metformin dual therapy by Inzucchi, S. E., Tunceli, K., Qiu, Y., Rajpathak, S., Brodovicz, K. G., Engel, S. S., Mavros, P., Radican, L., Brudi, P., Li, Z., Fan, C. P. S., Hanna, B., Tang, J., Blonde, L.

“…Aim To assess time to insulin initiation among patients with type 2 diabetes mellitus (T2DM) treated with sitagliptin versus sulphonylurea as add‐on to…”
Get full text

Patient-reported outcomes following treatment with the human GLP-1 analogue liraglutide or glimepiride in monotherapy: results from a randomized controlled trial in patients with type 2 diabetes by Bode, B.W, Testa, M.A, Magwire, M, Hale, P.M, Hammer, M, Blonde, L, Garber, A

“…Aim: As weight gain and hypoglycaemia associated with glimepiride therapy can negatively impact weight perceptions, psychological well-being and overall…”
Get full text

Comparison of vildagliptin and thiazolidinedione as add-on therapy in patients inadequately controlled with metformin: results of the GALIANT trial - a primary care, type 2 diabetes study by Blonde, L., Dagogo-Jack, S., Banerji, M. A., Pratley, R. E., Marcellari, A., Braceras, R., Purkayastha, D., Baron, M.

“…Aim: To assess the efficacy and tolerability of vildagliptin compared with thiazolidinediones (TZDs) as an add on to metformin treatment in a primary care…”
Get full text

PO415 GREATER PPG CONTROL ACROSS ALL 3 MAIN MEALS WITH LIRAGLUTIDE VS PLACEBO, WHEN ADDED ON TO METFORMIN AND ROSIGLITAZONE by Fulcher, G, Shomali, M, Blonde, L, Bode, B, Wang, F, Thomsen, H, Zinman, B

Get full text

Towards adapting current 3DTV for an improved 3D experience by Blonde, Laurent, Doyen, Didier, Thébault, Cédric, Huynh-Thu, Quan, Stoenescu, Daniel, Daniel, Emmanuel, de Bougrenet de La Tocnaye, Jean-Louis, Bentahar, Samir

“…Recent upgrades of HDTV into 3DTV resulted in impairments in displaying stereo contents. One of the most critical flaws is probably crosstalk and the resultant…”
Get full text

Does home-based exercise improve body mass index in patients with type 2 diabetes? Results of a feasibility trial by Krousel-Wood, M A, Berger, L, Jiang, X, Blonde, L, Myers, L, Webber, L

“…This feasibility trial evaluated the use, safety, and short-term benefits of a home-based exercise intervention designed to increase physical activity among…”
Get full text

Greater reductions in A1C in type 2 diabetic patients new to therapy with glyburide/metformin tablets as compared to glyburide co-administered with metformin by Blonde, L., Wogen, J., Kreilick, C., Seymour, A. A.

“…Background:  A cohort of patients with type 2 diabetes, prescribed glyburide/metformin tablets, experienced significantly greater improvements in glycaemic…”
Get full text

Patient-directed titration for achieving glycaemic goals using a once-daily basal insulin analogue: an assessment of two different fasting plasma glucose targets - the TITRATETM study by Blonde, L, Merilainen, M, Karwe, V, Raskin, P

“…To compare efficacy and safety of two fasting plasma glucose (FPG) titration targets [4.4-6.1 mmol/l (80-110 mg/dl) and 3.9-5.0 mmol/l (70-90 mg/dl)] using a…”
Get full text

In T2D patients with baseline A1c <8.0%, liraglutide achieves A1c targets more often than sitagliptin or exenatide by King, A, Montanya, E, Pratley, R, Blonde, L, Svendsen, C, Donsmark, M, Sesti, G

Get full text

The effect of the availability of inhaled insulin on glycaemic control in patients with Type 2 diabetes failing on oral therapy: the evaluation of Exubera® as a therapeutic option on insulin initiation and improvement in glycaemic control in clinical practice (EXPERIENCE) trial by Del Prato, S., Blonde, L., Martinez, L., Göke, B., Woo, V., Millward, A., Gomis, R., Canovatchel, B., Strack, T., Lawrence, D., Freemantle, N.

“…Aim  To examine the impact of inhaled human insulin (Exubera®, EXU) on patient or physician willingness to adopt insulin after oral glucose‐lowering agent…”
Get full text

Insulin degludec given in a flexible once-daily dosing regimen does not compromise efficacy or safety in type 2 diabetes by Rana, A, Meneghini, L, Atkin, S.L, Bain, S.C, Gough, S, Raz, I, Blonde, L, Johansen, T, Birkeland, K.I

Get full text

Glyburide/metformin combination product is safe and efficacious in patients with type 2 diabetes failing sulphonylurea therapy by Blonde, L, Rosenstock, J, Mooradian, A. D., Piper, B-A., Henry, D.

“…Aim: To compare the efficacy, safety and tolerability of a fixed combination glyburide/metformin preparation with those of glyburide or metformin alone in…”
Get full text

Does home-based exercise improve body mass index in patients with type 2 diabetes? by Krousel-Wood, M.A, Berger, L, Jiang, X, Blonde, L, Myers, L, Webber, L

“…Abstract Aims This feasibility trial evaluated the use, safety, and short-term benefits of a home-based exercise intervention designed to increase physical…”
Get full text